NASDAQ: SNCE - Science 37 Holdings, Inc.

Rentabilité sur six mois: 0%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Calendrier des promotions Science 37 Holdings, Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Science 37 Holdings, Inc.

Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data.

plus de détails
The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

IPO date 2020-11-20
ISIN US8086441081
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.science37.com
Цена ао 5.75
Changement de prix par jour: 0% (5.75)
Changement de prix par semaine: 0% (5.75)
Changement de prix par mois: 0% (5.75)
Changement de prix sur 3 mois: 0% (5.75)
Changement de prix sur six mois: 0% (5.75)
Changement de prix par an: +7.68% (5.34)
Evolution du prix sur 3 ans: -52.6% (12.13)
Evolution du prix sur 5 ans: 0% (5.75)
Evolution des prix sur 10 ans: 0% (5.75)
Evolution des prix depuis le début de l'année: 0% (5.75)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 0.6789 10
P/BV 0.489 10
P/E 0 0
EV/EBITDA 0.4243 10
Total: 6.25

Efficacité

Nom Signification Grade
ROA, % -26.33 0
ROE, % -46.57 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -0.0093 10
Total: 9.8

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 154.27 10
Rentabilité Ebitda, % 426.07 10
Rentabilité EPS, % 11478.95 10
Total: 10
Plus de détails

Établissements Volume Partager, %
Redmile Group, LLC 990412 0.83
Kent Lake Capital, LLC 278560 0.23
Glynn Capital Management Llc 176992 0.15
Russell Investments Group, Ltd. 169696 0.14
Vanguard Group Inc 160367 0.13
Alphabet Inc. 160364 0.13
MIC Capital Management UK LLP 117295 0.1
Alyeska Investment Group, L.P. 88319 0.07
Citadel Advisors Llc 67631 0.06
Samsara BioCapital, LLC 45000 0.04



Superviseur Titre d'emploi Paiement Année de naissance
Mr. David Coman CEO & Director 796.13k 1970 (55 années)
Ms. Christine A. Pellizzari J.D. Chief Legal & Human Resources Officer and Secretary 521.58k 1968 (57 années)
Ms. Darcy Forman Chief Delivery Officer 550.58k 1976 (49 années)
Mr. Mike Zaranek Chief Financial Officer N/A 1971 (54 année)
Irena Lambridis VP and Head of Quality Assurance & Compliance N/A
Ms. Margie Gimbel Kooman Vice President of Marketing & Communications N/A
Mr. Drew Bustos Chief Strategy & Marketing Officer N/A
Mr. Jonathan Cotliar M.D. Chief Medical Officer 486.6k 1972 (53 année)
Mr. Michael Shipton Chief Commercial Officer N/A 1972 (53 année)
Mr. Tyler Van Horn VP of Corporate Strategy & Chief of Staff N/A

Adresse: United States, Research Triangle Park. NC, 800 Park Offices Drive - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.science37.com